3.4.17.23	medicine	17-beta-estradiol may reduce SARS-CoV-2 infection of lung epithelial cells	764554	
3.4.17.23	drug development	a super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection	763700	
3.4.17.23	pharmacology	ACE 2 is a potential therapeutic target in the treatment of heart failure	708649	
3.4.17.23	medicine	ACE-2 protects against lung fibrogenesis by limiting the local accumulation of the profibrotic peptide angiotensin II	677486	
3.4.17.23	medicine	ACE2 activators are a reliable approach which could lead to the development of a novel class of antihypertensive and cardioprotective drugs	693702	
3.4.17.23	medicine	ACE2 is a functional receptor for the causative agent of severe acute repiratory syndrome, the SARS coronavirus, ACE2 also plays a role in the development of liver fibrosis and subsequent cirrhosis	678102	
3.4.17.23	medicine	ACE2 is a key factor for protection from ARDS/acute lung injury and it functions as a critical SARS receptor in vivo, recombinant ACE2 protein might not only be a treatment to block spreading of SARS but also to protect SARS patients from developing lung failure	679135	
3.4.17.23	diagnostics	ACE2 levels is a putative early biomarker of SARS-CoV-2 infection severity	763771	
3.4.17.23	medicine	ACE2 may be a target for therapeutic interventions that aim to reduce albuminuria and glomerular injury	680388	
3.4.17.23	pharmacology	ACE2 might be a target for treatment of non-small cell lung cancer	710171